Murrieta, CA, United States of America

John Stine

This inventor holds 3 USPTO granted patents. Top assignee: Syneron Medical Ltd.. Active years: 2015.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 3

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Spotlight: John Stine and His Contributions to Skin Treatment Technology

Introduction: John Stine, a dedicated inventor based in Murrieta, California, has made significant contributions to the field of skin treatment technology. With a total of three patents to his name, Stine exemplifies the spirit of innovation that drives advancements in medical and cosmetic applications.

Latest Patents: Among his most recent achievements are two notable patents: "Apparatus for Skin Treatment" and "Applicator for an Apparatus for Skin Treatment." These inventions showcase his commitment to developing effective tools that enhance skin health and improve treatment outcomes.

Career Highlights: John Stine is currently affiliated with Syneron Medical Ltd., a company renowned for its innovative medical technologies. His work within this organization underscores his pivotal role in the pursuit of innovative solutions in skin health.

Collaborations: Collaboration is key in the world of inventions, and Stine has had the opportunity to work alongside notable colleagues such as Shlomo Assa and James Bartholomeusz. Together, they combine their expertise to push the boundaries of skin treatment technologies.

Conclusion: John Stine's contributions to skin treatment through his innovative patents and collaboration with talented professionals highlight the importance of continual research and development in the field. As technology evolves, inventors like Stine are at the forefront of creating solutions that improve the quality of life for many individuals seeking effective skin treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…